2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theCancer Cachexia Market?

The cancer cachexia market is expected to boom due to the rising occurrence of cancer. This medical condition characterised by unregulated growth of anomalous cells forms tumors and interferes with the body’s normal processes. The increase in cancer cases can be ascribed to varying factors such as lifestyle shifts, environmental issues, aging population, hereditary factors, enhanced diagnostics enabling early detection, and heightened awareness driving more people towards medical help. Evolution in medical technology along with the growth in understanding cancer complications reinforces the frequency of identifying and reporting cancer cachexia. The healthcare sector is ameliorating their capabilities of recognising cachexia symptoms which facilitates timely interventions and initiation of treatments. For example, data from the Australian Bureau of Statistics, revealed that approximately 1.8% of the population, or 456,200 individuals, were diagnosed with cancer in Australia in 2022. Further, The National Cancer Institute predicts that in 2024, a projected 2,001,140 new cancer cases and 611,720 deaths are expected in the U.S. In 2022, there were nearly 20 million newly diagnosed cases and 9.7 million cancer-associated casualties worldwide. By 2040, the yearly new cases of cancer are anticipated to escalate to 29.9 million, and the death toll to 15.3 million. Hence, the upward trend in the occurrence of cancer is fuelling the expansion of the cancer cachexia market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15527&type=smp

#What Long-Term Growth Rate is Expected for theCancer Cachexia Market Between 2025 and 2034?

Recent years have witnessed a substantial increase in the cancer cachexia market size. It will expand from $2.47 billion in 2024 to $2.62 billion a year later, with a compound annual growth rate (CAGR) of 6.4%. The rise in the past period is due to enhanced knowledge of cancer biology, the rising incidence of cancer, an aging population, a heightened emphasis on patient-focused care, extended treatment choices, and increasing consciousness among healthcare professionals.

The market size of cancer cachexia is projected to witness substantial growth in the forthcoming years, reaching $3.33 billion by 2029 with a compound annual growth rate (CAGR) of 6.2%. This anticipated growth within the prediction period can be credited to the growing awareness related to cachexia management, increasing elderly population, adoption of innovative therapeutic strategies, escalating healthcare spending, and advantageous government initiatives. Principal trends within this forecasted period encompass heightened efforts in research and development, widening therapeutic alternatives, better diagnosis rates, uptake of groundbreaking treatment modalities, and progress in supportive care techniques.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15527

What Are the Current Market Growth and Trends in theCancer Cachexia Market That Industry Players Should Watch?

Leading firms in the cancer cachexia market are pioneering new drug therapies, such as monoclonal antibodies for cachexia, to establish specialized treatment for cancer cachexia, geared towards enhancing body weight, muscle content, and overall life quality for affected individuals. A monoclonal antibody for cachexia identifies and restricts components leading to muscle and weight reduction. For example, Pfizer Inc., an American pharmaceutical enterprise, proclaimed the encouraging outcomes of its Phase 2 examination for Ponsegromab, a monoclonal antibody targeting GDF-15, in cancer cachexia patients, in September 2024. The test displayed a significant rise in body weight coupled with enhancements in muscle mass, hunger, and physical activity, with the 400 mg dosage presenting the most compelling outcomes. Based on these optimistic results, Pfizer intends to commence registration-empowering examinations in 2025 to delve deeper into Ponsegromab’s potential uses in combating cancer cachexia.

What Are the Major Market Players Making an Impact on theCancer Cachexia Market Growth?

Major companies operating in the cancer cachexia market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Novartis International AG, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Kyowa Kirin Co. Ltd., Hikma Pharmaceuticals plc, Endo International plc, Aspen Pharmacare Holdings Limited, Lupin Limited, Mallinckrodt plc, Akorn Inc., Aeterna Zentaris, XBiotech Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/cancer-cachexia-global-market-report

How Are the Key Segments of the Cancer Cachexia Market Driving Opportunities and Innovations?

The cancer cachexia market covered in this report is segmented –

1) By Therapeutics: Progestogens, Corticosteroids, Combination Therapies, Other Therapeutics

2) By Mechanism Of Action: Appetite Stimulators, Weight Loss Stabilizers, Other Mechanisms Of Actions

3) By Distribution Channel: Hospital Stores, Retail Pharmacy Stores, Online Pharmacies

Subsegments:

1) By Progestogens: Megestrol Acetate, Medroxyprogesterone Acetate, Hydroxyprogesterone Caproate

2) By Corticosteroids: Dexamethasone, Prednisolone, Methylprednisolone

3) By Combination Therapies: Progestogens + Corticosteroids, Progestogens + Anabolic Agents, Corticosteroids + Anabolic Agents

4) By Other Therapeutics: Anabolic Agents, Appetite Stimulants, Anti-inflammatory Drugs, Nutritional Supplements

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15527&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theCancer Cachexia Market?# Market Expansion?

North America was the largest region in the cancer cachexia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer cachexia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Cancer Cachexia Market 2025, By The Business Research Company:

Appendiceal Cancer Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/appendiceal-cancer-treatment-global-market-report

Breast Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Bone Cancer Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bone-cancer-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: